I do find it very hard to believe, PAR didn’t model out a number...

I do find it very hard to believe, PAR didn’t model out a number of different scenarios, in anticipation for 2mg dose and the updated IND. I also suspect the FDA comments have been known for over a month and weren’t declared to the market on time.

Given the dire financial situation at hand, any lag here is taken as a huge red flag that “they” are busy cold calling “selling” and not signing. Tut tut Paul! What have you been actually doing?

I think most are aware of this sorry state of affairs and as time ticks on, we sit and wait, thinking of how little activity has been ongoing underneath the water as we drown.

I have to laugh at the conduct of this company, from the investor relation intern to the fumbling MD.

Clock ticks, things are getting bad again.